- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07580378
Exploration of Acceptability of Alcohol Interventions
A Mixed-methods Study Exploring the Acceptability of Psychosocial Interventions and Social Determinants of Engagement With an NHS-led Alcohol Care Service.
Descripción general del estudio
Estado
Condiciones
Descripción detallada
The study will initially consists of a qualitative element assessing the acceptability of psychosocial interventions from the ITEP Manual, delivered by clinical staff, utilising a tailored version of the evidence-based, generic theoretical framework of acceptability questionnaire (Sekhon et al., 2022). This meets the ontological epistemology of a qualitative approach, based upon by its' focus on elicitation of subjective experience, perceptions and effort, in relation to the acceptability of delivering psychosocial interventions (Tombs and Strange, 2024). Assessing this is of particularly importance, as whilst the ITEP Manual has a strong evidence base for successful behaviour change, measures of acceptability regarding delivery are less well evidenced and have been postulated to influence clinicians' readiness to initiate behaviour change conversations, prospectively affecting patient outcomes (Bull et al., 2021).
The study will also investigate the correlation between demographic variables and engagement with a North West England, NHS-led, alcohol care service, amongst the patient population. Measures of interest will be based on existing, routinely captured data, including alcohol consumption (Audit-C/ AUDIT scores), and demographic variables of age, gender and socioeconomic status. Engagement can be defined in this case, as patient contact with the service, which might lead to referral to treatment and onward referral (although these latter variables are outside the scope of the current study). The social determinants of health are known to contribute to poorer outcomes, hence identification of those not engaging with such services, offers new opportunities to improve population health (Fraser et al., 2022; Hiam, 2025). Indeed, this philosophy aligns with the NHS 10-year plan which acknowledges the intolerable and detrimental health outcomes of polarised groups in UK society, with clear objectives set out to tackle inequalities in both access and outcomes (NHS, 2025).
It is anticipated that this study will contribute to our understanding of the importance of measuring the acceptability of delivering health behaviour interventions, amongst NHS clinical staff, delivering evidence-based psychosocial interventions. It is also anticipated the study will distinguish which social determinants of health, correlate to engagement with an NHS-based alcohol care service. It offers new opportunities to reflect on, and review current strategies for delivering on objectives, around ameliorating social inequalities within socially deprived areas (NHS, 2025). It may also highlight a need for more research to evaluate prospective improvement opportunities to reduce health inequalities, for those patient groups who are not engaging with such services.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Michelle Stephens, Trust Sponsor
- Número de teléfono: UK: 07976 152397
- Correo electrónico: research.sponsorship@elht.nhs.uk
Copia de seguridad de contactos de estudio
- Nombre: Aleksandra (Ola) Metryka, Chief Investigator
- Número de teléfono: 07977267956
- Correo electrónico: research.sponsorship@elht.nhs.uk
Ubicaciones de estudio
-
-
Lancashire
-
Burnley, Lancashire, Reino Unido, BB102pq
- Burnley General Teaching Hospital
-
Contacto:
- Número de teléfono: 07977297281
- Correo electrónico: christopher.gray@elht.nhs.uk
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Part 1: The participants for part 1 will be identified by the former service lead, who still works in the Trust. A list of all the clinical staff who worked in the alcohol care service will be provided to the Chief Investigator, in order to facilitate contact, with prospective participants.
Part 2: Patients who had contact with the East Lancashire NHS-Health Trust alcohol-care service, between September 2023 and December 2024 (but who have not opted-out of their data being utilised for research purposes).
Descripción
Inclusion Criteria:
- Clinical staff who worked in the ELHT alcohol care service, and received training in the delivery of psychosocial interventions using the ITEP Manual, and who are still employed by ELHT in other roles (following de-commissioning of the alcohol care service).
- Patient data under part 2 of the study, who have not opted to have their data removed, in accordance with the NHS MESH, opt out scheme.
Exclusion Criteria:
- Clinical staff who worked in the ELHT alcohol care service, but who no longer work for the trust, or are retired.
- Clinical staff who did not receive training in the delivery of psychosocial interventions.
- Any patient data under part 2 of the study, who have opted to have their data removed for use, under the NHS MESH protocols.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Clinical ataff who delivered psychosocial interventions and staff who engaged with the service
The participants for part 1 will be identified by the former service lead, who still works in the Trust. A list of all the clinical staff who worked in the alcohol care service will be provided to the Chief Investigator, in order to facilitate contact, with prospective participants. This will be done via email correspondence on Trust computers, to work-based email addresses, to ensure that all correspondence within the study, is protected by Trust IT security. Part 2: The data pertaining to the patient contacts between September 2023 and December 2024, will be screened by the NHS England MESH team to determine if any patients have opted out of sharing their data for research purposes. Once confirmed, the residual data between September 2023 and December 2024 will then be reviewed for inclusion in the data analysis. That is, given that data is captured from a single-time point, for each data set (i.e. there is no intervention follow-up data to compare against). |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Acceptability of delivering psychosocial interventions & social determinants of access to an NHS-led Alcohol-Care service.
Periodo de tiempo: Anticipated to be no longer than 3 months
|
Directed Content Analysis (DCA) will be used to analyse data from the outputs of the TFA-based questionnaire regarding the acceptability of interventions (Hsieh et al., 2005; Sekhon., et al, 2022). Descriptive statistics will be used to describe the current patient contact data from patients who engaged with the service during September 2023 and December 2024. |
Anticipated to be no longer than 3 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Christopher Gray, Chief Investigator, East Lancashire NHS-Health Trust
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- DEV116
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .